144 related articles for article (PubMed ID: 17177292)
1. The commonality of plasticity underlying multipotent tumor cells and embryonic stem cells.
Postovit LM; Costa FF; Bischof JM; Seftor EA; Wen B; Seftor RE; Feinberg AP; Soares MB; Hendrix MJ
J Cell Biochem; 2007 Jul; 101(4):908-17. PubMed ID: 17177292
[TBL] [Abstract][Full Text] [Related]
2. Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells.
Postovit LM; Margaryan NV; Seftor EA; Kirschmann DA; Lipavsky A; Wheaton WW; Abbott DE; Seftor RE; Hendrix MJ
Proc Natl Acad Sci U S A; 2008 Mar; 105(11):4329-34. PubMed ID: 18334633
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA reins in embryonic and cancer stem cells.
Mallick B; Chakrabarti J; Ghosh Z
RNA Biol; 2011; 8(3):415-26. PubMed ID: 21525784
[TBL] [Abstract][Full Text] [Related]
4. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNAs in normal and pathological pluripotency.
Häfner SJ; Talvard TG; Lund AH
Semin Cell Dev Biol; 2017 May; 65():1-10. PubMed ID: 27438587
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta superfamily in mouse embryonic stem cell self-renewal.
Galvin-Burgess KE; Vivian JL
Vitam Horm; 2011; 87():341-65. PubMed ID: 22127250
[TBL] [Abstract][Full Text] [Related]
7. Stem cell plasticity in development and cancer: epigenetic origin of cancer stem cells.
Shah M; Allegrucci C
Subcell Biochem; 2013; 61():545-65. PubMed ID: 23150267
[TBL] [Abstract][Full Text] [Related]
8. In vivo generation of neural tumors from neoplastic pluripotent stem cells models early human pediatric brain tumor formation.
Werbowetski-Ogilvie TE; Morrison LC; Fiebig-Comyn A; Bhatia M
Stem Cells; 2012 Mar; 30(3):392-404. PubMed ID: 22213600
[TBL] [Abstract][Full Text] [Related]
9. Roles of TGF-β family signals in the fate determination of pluripotent stem cells.
Itoh F; Watabe T; Miyazono K
Semin Cell Dev Biol; 2014 Aug; 32():98-106. PubMed ID: 24910449
[TBL] [Abstract][Full Text] [Related]
10. Convergent mechanisms in pluripotent stem cells and cancer: implications for stem cell engineering.
Mooney BM; Raof NA; Li Y; Xie Y
Biotechnol J; 2013 Apr; 8(4):408-19. PubMed ID: 23418009
[TBL] [Abstract][Full Text] [Related]
11. Embryonic stem cell markers expression in cancers.
Schoenhals M; Kassambara A; De Vos J; Hose D; Moreaux J; Klein B
Biochem Biophys Res Commun; 2009 May; 383(2):157-62. PubMed ID: 19268426
[TBL] [Abstract][Full Text] [Related]
12. Epigenetically reprogramming metastatic tumor cells with an embryonic microenvironment.
Costa FF; Seftor EA; Bischof JM; Kirschmann DA; Strizzi L; Arndt K; Bonaldo Mde F; Soares MB; Hendrix MJ
Epigenomics; 2009 Dec; 1(2):387-98. PubMed ID: 20495621
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of LEFTY-expressing cells in early human embryoid bodies.
Dvash T; Sharon N; Yanuka O; Benvenisty N
Stem Cells; 2007 Feb; 25(2):465-72. PubMed ID: 17038673
[TBL] [Abstract][Full Text] [Related]
14. DNA Damage in Stem Cells.
Vitale I; Manic G; De Maria R; Kroemer G; Galluzzi L
Mol Cell; 2017 May; 66(3):306-319. PubMed ID: 28475867
[TBL] [Abstract][Full Text] [Related]
15. Stem cells, cancer stem-like cells, and natural products.
Efferth T
Planta Med; 2012 Jun; 78(10):935-42. PubMed ID: 22573366
[TBL] [Abstract][Full Text] [Related]
16. CSCs and pluripotent/multipotent stem cells.
Mod Pathol; 2017 Oct; 30(10):1336-1337. PubMed ID: 28972581
[No Abstract] [Full Text] [Related]
17. Formula G1: Cell cycle in the driver's seat of stem cell fate determination.
Julian LM; Carpenedo RL; Rothberg JL; Stanford WL
Bioessays; 2016 Apr; 38(4):325-32. PubMed ID: 26857166
[TBL] [Abstract][Full Text] [Related]
18. Use of xenofree matrices and molecularly-defined media to control human embryonic stem cell pluripotency: effect of low physiological TGF-beta concentrations.
Peiffer I; Barbet R; Zhou YP; Li ML; Monier MN; Hatzfeld A; Hatzfeld JA
Stem Cells Dev; 2008 Jun; 17(3):519-33. PubMed ID: 18513159
[TBL] [Abstract][Full Text] [Related]
19. Control of early fate decisions in human ES cells by distinct states of TGFbeta pathway activity.
Greber B; Lehrach H; Adjaye J
Stem Cells Dev; 2008 Dec; 17(6):1065-77. PubMed ID: 18393632
[TBL] [Abstract][Full Text] [Related]
20. Emerging role of Notch in stem cells and cancer.
Wang Z; Li Y; Banerjee S; Sarkar FH
Cancer Lett; 2009 Jun; 279(1):8-12. PubMed ID: 19022563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
